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Abstract. This work describes a series of fluorescent 2,1,3-benzothiadiazole derivatives (neutral, singly-
charged and doubly-charged) to act as bioprobes for mitochondria. The results showed the flaws in the 
molecular architecture of this class of fluorophores and our attempts to direct the synthesized derivatives 
to the organelle. Unexpected results also showed a need for new strategies to predict the cellular selectivity 
of these derivatives. One of the singly-charged derivatives could stain mitochondria selectively whereas 
the doubly-charged stained the plasma membrane in an unexpected but highly selective manner. Co-
staining experiments confirmed the cellular localization of the new derivatives. EPR experiments 
demonstrated the fluorescent marker that is selective for mitochondria does not interfere in the ROS 
production of the cells.  
Keywords. Benzothiadiazole, mitochondria, plasma membrane, fluorescence, cell-imaging, bioprobe, 
molecular architecture.   
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Introduction  
The use of fluorescent bioprobes has boosted the knowledge of molecular and cellular 
biology to a higher level.1-3 The possibility of selectively monitoring organelle and 
cellular components with fluorescent small molecules has opened up new perspectives 
towards the development of medicines and to control specific cellular events.4-6 Several 
strategies have been developed during the last decades to improve bioprobe selectivities 
and stabilities and to overcome several drawbacks such as signal-to-noise ratio, fade off, 
blinking and membrane permeability.7-9  
 Despite the huge progress observed in the field of bioimaging using molecular 
bioprobes, there is still much room for improvements and creative applications of both 
new strategies and new fluorophores.10 Most state-of-the-art fluorophores are based on a 
molecular architecture comprising classic scaffolds such as coumarins, boron-
dipyrromethenes, fluoresceins, rhodamines, cyanines, and phenoxazines.11-13 These 
fluorophores have, however, already shown limitations and drawbacks associated with 
their use. In this sense, several groups are developing new bioprobes derived from other 
heterocyclics (Figure 1) such as phenazines,14 quinolines,15 pyridines,16 imidazolones,17 
indoles,18 pyrimidines,19 benzothiadiazoles20 and others.21-30  
 A significant challenge pertains to the appropriate design of stable and efficient 
fluorophores capable of specific responses inside the astonishing and multifactorial 
environment of living cells. For some, the ability to transpose the cellular membrane is 
among the most desirable feature of a fluorogenic probe.10 Whether capable of 
transposing the cells’ membranes, the probe should specifically stain an organelle or cell 
component without altering the cellular homeostasis and without interfering in the cells’ 
normal function.  
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Figure 1. Examples of fluorescent small organic molecules structures based on non-classical heterocyclic 
scaffolds. 
 
 Mitochondria are among the most important organelles, often referred to as “the 
guardian of the gate between life and death”.31 The complexity of mitochondria and their 
functions in cell regulation32 render these organelles as outstanding targets to be studied 
by using fluorescent selective cell markers,33-35 as highlighted elsewhere.36 Although 
there are a few commercial probes to stain mitochondria, their limitations are well 
documented.37 For instance, reactive oxygen species (ROS) imbalances may be a 
consequence of specific mitochondrial labelling by a new fluorophore, but this issue is 
not addressed when a new mitochondrial marker is published, unless the bioprobe is 
developed to detect ROS, as described in several and recent examples.38-48  
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We have already disclosed some mitochondrial markers such as fluorescent 
peptoids,49 lapachone-based structures,50 Goniothalamin derivative,51 multicomponent 
adducts52 and benzothiadiazole derivatives.53 2,1,3-Benzothiadiazole (BTD) is a new 
class of fluorescent cell markers, as we have disclosed elsewhere.54 This heterocyclic has 
several attractive photophysical properties55-57 and is typically very stable upon light 
excitation, as noted in several works.58-87 After our pioneering works using -extended 
BTDs as cellular markers,54 several groups published fluorescent BTD derivatives for 
different organelles and cells’ components selective staining with success.88-99  
 Despite the many strides in the development of new and selective BTD markers, 
there still remains much work to be done. For instance, it is necessary to study the 
commonly used strategies to direct fluorophores inside living cells to a specific organelle 
using fluorescent BTDs. Some strategies to target mitochondria with organelle-specific 
fluorophores have been reviewed elsewhere.100-103 The application of such principles, as 
in the use of a triphenylphosphonium (TPP) cation usually is a good alternative, as shown 
in many available reports.104-106 Indeed, the use of TPP cation allows several molecules 
and molecular systems to reach the mitochondrial machinery, as recently reviewed.107 
Another attractive idea is the use of charged lipophilic derivatives (typically cations) 
rather than TPP ions aiming at taking advantage of the highly negative membrane 
potential of the mitochondrial membrane (≈ -180 mV).36  
 Due to our interest and ongoing efforts to develop the chemistry of selective 
fluorescent BTDs,54 we disclose herein a series of fluorescent BTD derivatives and their 
different cellular responses inside living and fixed cells using the logical chemical 
synthesis and based on the commonly used strategies to targeting mitochondria with these 
fluorophores.  
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Results and Discussion  
The first description of a fluorescent BTD capable of selectively staining mitochondria 
was reported by our group in 2012108 and it was based on the conjugation of the 2-
aminopyridine to the BTD core (Figure 2). Later, based on this work108 and in other work 
from our group,20 Hou and co-workers93 described the use of two 4-aminopyridine BTD-
substituted derivatives (mono- and bis-substituted) for cell imaging. The mono-
substituted derivative bearing a bromide atom on the other side (7-position) showed a 
preference for mitochondria (Figure 2) allowing the use of the probe for quantitative 
intracellular pH imaging.93 In the current work, we envisaged the use of aminopyridine 
mono-substituted BTDs to evaluate their cellular response (Figure 2) and the possibility 
of using singly- and doubly-charged lipophilic derivatives based on this primary scaffold 
aiming at the development of a class of BTD-based mitochondrial markers.  
 
Figure 2. Fluorescent BTDs bearing the aminopyridine group previously described by us,108 by others93 
and the molecular architecture evaluated in the current work. Note the possibility of singly- and doubly-
charged lipophilic cations beyond the neutral primary scaffold based on the incorporation of the 4-
aminopyridine group to the BTD core.  
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 The new derivatives were synthesized as shown in Scheme 1. The Buchwald-
Hartwig protocol was used to promote the synthesis of BTD-4AP (85%) starting from 
the commercially available BTD-Br. BTD-4AP could be directly alkylated affording two 
singly-charged cationic derivatives i.e. BTD-4APBu (50%) and BTD-4APOc (60%). 
The synthesis of doubly-charged lipophilic di-cation BTD-4APBuP (27%) was also 
carried out by directly alkylation to incorporate the TPP group to the structure aiming at 
directing the new structure to the mitochondria, as will be disclosed in due course.  
 
Scheme 1. Synthesis of the fluorescent BTDs derivatives tested in this work. 
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All compounds were fully characterized (see the Experimental Section for details 
and the Supporting Information file) and their photophysical properties were evaluated as 
shown in Figure 3 and Table 1. 
 
Table 1. UV-Vis and fluorescence emission data (in different solvents at 10 M for all analyses) for the 
synthesized compounds. 
Compound Solvent max(abs) (nm) Log  max(em) (nm) 
Stokes Shift (nm / 
cm-1) 
      
BTD-4AP 
CH2Cl2 404 3.9 543 139 / 6336 
DMSO 417 3.9 570 153 / 6437  
MeCN 403 4.0 551 148 / 6665 
MeOH 402 3.8 572 170 / 7393 
Toluene 404 3.9 533 129 / 5991 
Water 362 3.9 552 190 / 9508 
BTD-4APOc 
     
CH2Cl2 367 3.4 525 158 / 8200 
DMSO 374 3.5 529 155 / 7834 
MeCN 363 3.3 517 154 / 8206 
MeOH 364 3.3 520 156 / 8242 
Toluene 379 3.4 509 130 / 6739 
Water 366 3.3 552 186 / 9206 
BTD-4APBu 
     
CH2Cl2 365 3.3 535 170 / 8706 
DMSO 375 3.2 526 151 / 7655 
MeCN 363 3.3 540 177 / 9030 
MeOH 365 3.3 521 156 / 8203 
Toluene 385 2.8 528 143 / 7035 
Water 365 3.2 550 185 / 9215 
BTD-4APBuP 
     
CH2Cl2 371 3.2 504 133 / 7113 
DMSO 372 2.8 527 155 / 7906 
MeCN 369 3.1 512 143 / 7569 
MeOH 362 3.2 519 157 / 8356 
Toluene 377 2.3 527 150 / 7550 
Water 367 3.2 538 171 / 8661 
Quantum yields of fluorescence109 of the dyes, respectively: 0.27, 0.04, 0.04, 0.01 in MeCN; 0.50, 
0.02, 0.01, 0.06 in toluene; 0.001, 0.007, 0.005, 0.050 in water.  
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Figure 3. UV-Vis, fluorescence and solvatochromic effect of the synthesized BTDs. From top to bottom: 
BTD-4AP, BTD-4APOc, BTD-4APBu, and BTD-4APBuP. 10 M for all analyses. 
 
 All BTD derivatives showed large Stoke shifts (133-190 nm) indicating their good 
stability to emit from the first excited-state trough intramolecular charge-transfer (ICT) 
processes. The relatively large R2 values of the solvatochromic effect (ETN vs cm-1) 
plotted using the values provided by Reichardt110 indicate efficient ICT stabilizing 
processes taking place from the first excited-state in accordance with the large Stokes 
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shifts. The calculated linear correlations from the plots also pointed to a considerable ICT 
contribution, as the obtained values are in accordance with the proposition of 
Radhakrishnan and co-workers.111 
 To a better understand of the photophysical properties of the synthesized 
derivatives, theoretical calculations were performed with fully optimized structure 
geometries (Figure 4).  
 
Figure 4. Optimized geometries of BTD-4AP (neutral), BTD-4APBu (cationic), BTD-4APBuP (di-
cationic), and BTD-4APOc (cationic) in vacuum as obtained at the CAM-B3LYP/6-31G(d) level of theory. 
 
The absorption maxima for the four BTDs in different solvents (PCM) were 
evaluated from the TD-DFT calculations with different exchange-correlation functionals 
(XCF) along with the 6-311G+(2d,p) basis set. The performances of the B3LYP, CAM-
B3LYP, LC-ωPBE, M06, M062X, and PBE1PBE were assessed to select the most 
suitable level of theory aiming at describing the electronic optical properties of the 
fluorogenic dyes. In Table S1 (see the Supporting Information file) it is summarized the 
calculated absorption maxima for the investigated small-molecules. As expected for this 
kind of -extended BTDs,112-116 the discussion is focused basically on the longest 
wavelength excitation mode i.e. in characterizing the -* transitions. 
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To obtain a more precise elucidation of the relative performances of the six XCF 
studied herein, a statistical analysis was performed and it is provided in Figure 5, where 
it is reported the mean absolute error (MAE) accounting for the maxima absorption peak 
position associated with the -* transitions. LC-PBE, and B3LYP to a lesser extent, 
provided less accurate positions than the other four XCF. As depicted from Figure 5, M06 
and PBE1PBE yielded the best overall performance across all studied solvents with 
absolute deviations below 20 nm, except for the case of BTD-4AP although the value is 
still acceptable, and therefore, these were selected as the “optimal” XCF to be studied in 
further detail. The relatively poor performance of LC-PBE in TD-DFT calculations 
including solvent effects (PCM) was already reported for other organic chromophores as 
discussed elsewhere.117 It turned out that the results obtained using M06 and PBE1PBE 
were essentially the same, so M06 was not included in the remainder of the discussion, 
reserving the M06 results to the Supporting Information section. 
 
Figure 5. Mean Absolute Error (MAE) comparing both the experimental and the theoretical max positions 
in different solvents for all BTDs studied herein. The computed max corresponds to the largest wavelength 
band associated to the S0 → S1 electronic excitations. All theoretical calculations were performed under the 
TD-DFT framework using different DFT exchange-correlation functionals along with the People-type basis 
set 6-311+G(2d,p). 
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The theoretical absorption spectra of the BTDs calculated at the PBE1PBE/6-
311+G(2d,p)//CAM-B3LYP/6-31G(d) level of theory were first determined, as shown in 
Figure S1 in the Supporting Information. On balance, the simulated absorption spectra 
exhibited the same behavior of the experimental excitation bands and the following 
should be considered: (i) the band associated with the longest  is much less intense when 
compared with the band associated with the shorter . (ii) the PCM solvation scheme did 
not result in significant solvatochromic shifts, which was also observed in the 
experimental measurements (Figure 3 and Table 1) where the nature of the solvent did 
not affect the position of the bands, with some exceptions in the cases of BTD-4AP in 
water and BTD-4APBu in toluene. At first glance, the simulated spectra in toluene 
showed somewhat erratic behavior for the cationic derivatives with the two bands 
showing a similar pattern. This was however also evident in the experimental 
measurement of the di-cationic BTD-4APBuP in toluene where the two bands exhibited 
the same intensity. 
The molecular orbitals involved in the S0 → S1 electronic excitations associated 
with the longest wavelength band are displayed in Figure 6 showing that these transitions 
are basically HOMO-LUMO type bearing strong -* character. LUMO orbitals were 
strictly centered on the BTD core, which is an expected feature owing to the strong 
electron withdrawing property of this heterocyclic. As shown in Figure 6, the HOMO 
orbitals do not spread beyond BTD-4AP basic scaffold when additional fragments are 
added to it, especially when BTD-4APBu is compared with BTD-4APOc, meaning the 
lengthening of the alkyl chain did not affect the -* transitions. These band peaks are 
basically at the same wavelength since additional sp3 carbons insert only low energy σ 
levels (see Figure S2). 
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Figure 6. PBE1PBE/6-311+G(2d,p)//CAM-B3LYP/6-31G(d) HOMO and LUMO orbitals of BTD-4AP, 
BTD-4APBu, BTD-4APBuP, and BTD-4APOc in acetonitrile involved in the S0 → S1 electronic 
excitation associated with the longest wavelength band.  
 
The theoretical results were basically in accordance with the experimental data 
and all features accounted indicate what the solvatochromic study already indicates i.e. 
the ICT stabilizing processes from the first excited states are favored for the designed and 
synthesized structures.  
All BTDs were then submitted to MTT tests to evaluate whether these derivatives 
had cytotoxicity effects or not (Figure S3). At 10 M of concentration, no cytotoxic effect 
is noted and it required 100 M and 24 h to an expressive effect, excepted for BTD-
13 
 
4APOc at 10 M and only for T47D lineage, but the probes were used much less 
concentrated than 10 M. After 24 h of analysis, therefore, no significant cytotoxic effect 
could be noted for these derivatives at low concentrations, thus indicating they could be 
evaluated as cell-imaging probes, especially considering the new probes were evaluated 
at 1 M.  
The new BTD derivatives had then their abilities as bioprobes initially assessed in 
MCF-7 (breast cancer cells). The initial tested compound i.e. BTD-4AP should in 
principle display a mitochondrial preference (also see Figure 2), but as seen in Figure S4, 
the dye was found dispersed in the cytosol with no clear preference for any organelle. The 
same response was obtained by changing the cells’ lineages and the fluorophore was again 
found dispersed in the cytosol for A2780 (human ovarian carcinoma cells, Figure S5), 
T47D (human breast tumor cells, Figure S6) and HUVEC (human umbilical vein 
endothelial cells, Figure S7) lineages. The obtained results were highly unexpected 
considering the presence of a bromine atom at 7-position of the BTD core (see Figure 2), 
as shown by Hou and co-workers,93 directs the dye exclusively to the mitochondria. The 
derivatives of the 2-aminopyridine (with or without a bromine atom as seen in Figure 2), 
as we demonstrated before,108 were also found exclusively at the mitochondria. These 
results indicate how difficult is the task of designing and predicting the cellular preference 
of a BTD bioprobe. 
 Aiming for a precise mitochondrial staining, we decided to alkylate the BTD-4AP 
with a n-butyl group affording BTD-4APBu. This derivative had two features to help 
towards a mitochondrial selection: (i) it was turned into a cationic dye and therefore prone 
to use the mitochondrial membrane potential to select this organelle;101 (ii) the presence 
of a n-butyl group improved the lipophilicity of the dye and this feature may help towards 
a mitochondrial preference.100 BTD-4APBu, when incubated with the same cells 
14 
 
lineages, returned as the net result a clear preference for selecting mitochondrial in both 
live and fixed cells (Figures S8-S11). The probe however showed leakage from the 
organelle being therefore only a reasonable marker, thus avoiding its use as a selective 
bioprobe to stain mitochondria. 
 Considering the only possible modification to sustain the basic envisaged scaffold 
(BTD-4AP) was the substituent at the nitrogen of the pyridyl group, and that the use of 
lipophilic butyl group alongside with the presence of a positive charge seemed to help 
toward the mitochondrial selection, we decided to use a larger side chain. An n-octyl 
group was therefore incorporated by a direct alkylation of the BTD-4AP affording the 
fluorescent derivative BTD-4APOc (see Scheme 1). The new derivative had in principle 
a more lipophilic character and this feature should assist the probe to reach the 
mitochondrial machinery with a higher affinity. When tested in live and fixed cells, the 
BTD-4APOc dye proved to be capable of an efficient mitochondrial staining with a bright 
green emission inside both live and fixed cells (Figure 7).  
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Figure 7. Fluorescent profile of different cells lineages incubated with BTD-4APOc (1 M) in live (A) 
and (B) and fixed cells (C) and (D). (I) MCF-7, (II) A2780, (III) T47D and (IV) HUVEC cells lineages. 
(A) and (C) Show the staining distribution obtained with of BTD-4APOc in cells cytoplasm with 
accumulation in the regions near to the nuclei, as indicated to white arrows (mitochondria). Note the 
accumulation in the cytoplasm (white arrows) in a region near to the cells’ nuclei in both samples, known 
to be rich in mitochondria. The nuclei in these images are represented by black voids indicated by the letter 
N. (B) and (D) Show the normal morphological aspects of the samples by phase contrast microscopy. Scale 
bar of 10 m. 
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 To an additional confirmation of the mitochondrial staining of the developed dye 
BTD-4APOc, co-staining experiments were conducted using the commercially available 
MitoTracker Red and the results are shown in Figure 8.  
 
Figure 8. Co-staining experiment using MitoTracker Red (red emission) and BTD-4APOc (green 
emission) in live MCF-7 cells. (A) Mitochondria stained with BTD-4APOc. (B) Overlay of (A) and (C) 
showing the yellow to orange emission as the result of green plus red. (C) Mitochondria stained with 
MitoTracker Red. (D) Shows the normal morphology of the cells by phase contrast microscopy. The letter 
N indicates the nuclei of the cells. Scale bar of 10 m. 
 
 It was also performed a quantitative analysis using the Pearson’s correlation 
coefficient (PCC)118-120 between the two fluorescent signals, that is, the green emission 
from BTD-4APOc and the red emission from MitoTracker. Figure S15 summarizes this 
find. Data were obtained from ten independent analysis of ten different images. The 
quantitative results by PCC strong corroborate with the qualitative analysis (Figure 8), 
therefore showing the distribution within the cells (inside of mitochondria) are noted for 
both dyes. The negative control were performed using BTD-4APOc 90° 
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counterclockwise rotation and provides additional evidence that none random 
colocalization had occurred (See Figure S15).  
The live cells could be stained selectively with both markers localized at the 
mitochondria. The fixed cells, however, could not be co-localized because the 
commercially available MitoTracker Red is known to be dependent on the membrane 
potential of the organelle to be used as a selective mitochondrial fluorescent dye. 
According to the manufacturer, this compound is suitable only to stain live cells because 
of its dependency on the mitochondria membrane potential to work. MitoTracker dyes 
are cationic fluorophores that accumulate electrophoretically into the mitochondria as a 
response to the highly negative mitochondrial membrane potential. MitoTracker dyes also 
possess a reactive chloromethyl group that affords a covalent bond with thiols of proteins 
and peptides, trapping therefore MitoTracker dyes within the mitochondria. In this sense, 
when the experiment is performed with fixed cells (Figure 9), no fluorescence is noted 
with the known commercial dye, but in the meantime an intense green fluorescence is 
observed when the developed dye is tested. These results show the new BTD-4APOc is 
not dependent on the mitochondrial membrane potential to select this important organelle, 
being therefore a huge advantage over the available and most used marker.  
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Figure 9. Co-staining experiment using MitoTracker Red (red emitter) and BTD-4APOc (green emitter) 
in fixed MCF-7 cells. (A) Mitochondrial selective staining of fixed cells with BTD-4APOc. (B) Fixed cells 
stained with MitoTracker Red. No fluorescence is noted because the dye is dependent on the membrane 
potential of the organelles. (C) Shows the normal morphology of the cells by phase contrast microscopy. 
The letter N indicates the nuclei of the cells. Scale bar of 10 m.  
 
We also decided to evaluate the strategy of incorporating the TPP group in the 
structure of BTD-4APBu to improve its selectivity towards mitochondria, that is, to 
evaluate the classical strategy to direct a fluorogenic dye to the mitochondrial structure. 
As shown in Scheme 1, BTD-4APBuP was obtained straight from BTD-4AP and the 4-
carbons side chain was maintained in the structure of the doubly-charged fluorogenic dye. 
The fluorophore was then assessed in MCF-7 cells and the results are visualized in Figure 
10. 
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Figure 10. Fluorescent profile of MCF-7 cells lineage incubated with BTD-4APBuP (1 M) in live (A) 
and (B) and fixed cells (C) and (D). (A) and (C) Show the staining distribution obtained with of BTD-
4APBuP in the plasma membrane of the cells. The nuclei in these images are represented by black voids 
indicated by the letter N. (B) and (D) Show the normal morphological aspects of the samples by phase 
contrast microscopy. The dye was found accumulated in the peripheral region of the cellular membrane 
(white arrows) in both samples. The nuclear membranes in fixed samples (C) were slight stained (yellow 
arrows). Scale bar of 10 m. 
 
 The results obtained in the tests of BTD-4APBuP were highly unexpected. The 
probe bearing the TPP group should display a clear preference for mitochondria, but the 
probe was found in the plasma membrane exclusively. The latter is responsible for the 
boundary of the cells and the events such as cellular division, endocytosis, exocytosis, 
apoptosis and signal transduction are associated with this specific and complex cellular 
structure.121 The development of plasma membrane-selective probes is a huge 
challenge122, 123 and few molecular probes fulfill the requirements to be used as selective 
bioprobes for this task.124-126 Although it was designed in principle to stain mitochondria, 
the surprising results obtained for BTD-4APBuP were excellent. In Figure 10-C, tumor 
cells in the final cytokinesis step are observed, during cellular division with the plasma 
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membrane clearly delineated by the green emission of the new BTD. Although there is 
no doubt regarding the selectivity of the bioprobe, confirmatory experiments using the 
commercially available plasma membrane marker known as CellMask were conducted 
(Figure 11). The cell membrane specific marker was then tested in different cell lineages 
with similar results, as seen in Figures S12-S14.  
 
Figure 11. Co-staining experiment using the commercially available CellMask (red emission) and BTD-
4APBuP (green emission) in (I) live and (II) fixed MCF-7 cells. (A) Plasma membrane stained with BTD-
4APBuP. (B) Overlay of (A) and (C) showing the yellow to orange emission as the result of green plus red. 
(C) Plasma membrane stained with CellMask. (D) Shows the normal morphology of the cells by phase 
contrast microscopy. Arrows indicate the peripherical accumulation of the dyes in the plasma membrane. 
Note that in (II) the nuclear membrane is also stained by both dyes. The letter N indicates the nuclei of the 
cells. Scale bar of 10 m. 
 
 In fixed cells (Figure 11-II), the nuclear membranes were also found stained with 
both dyes. The fixative procedures with formalin compromise the membrane integrity 
turning the plasma membrane permeable for both the developed dye (BTD-4APBuP) and 
CellMask. These two dyes have affinity for the nuclear membrane, which may be stained 
only when fixed cells are used, as shown in Figure 11.  
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 Quantitative analyses by PCC were once more performed for both live and fixed 
cells (Figures S16 and S17, respectively). A PCC of 0.87 was obtained for the live cells 
and of 0.75 for the fixed cells. As expected, the fixed cells had a slighter lower PCC value 
as a consequence of membrane integrity loss as a consequence of fixative procedures. 
Finally, electron paramagnetic resonance (EPR) experiments were performed to 
evaluate the influence of the selective mitochondrial marker (BTD-4APOc) over the ROS 
production of the cells. EPR is currently used to a precise determination of intracellular 
ROS content.127 To quantify the ROS production, EPR was combined with the spin probe 
CMH (1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethyl-pyrrolidine), which reacts 
rapidly with the cellular ROS and affords detectable nitroxide radical (CM•). The ROS 
content is quantified by the CMH oxidation, which affords the EPR detectable nitroxide 
radical (CM•) bearing a half-life of h.128 The following analyses were therefore carried 
out: (i) negative control experiments to determine the cellular basal level of ROS (with 
no ROS induction), (ii) analyses in the presence of N-acetylcysteine for cellular ROS 
inhibition, (iii) with menadione for inducing the cellular ROS generation and, at last, (iv) 
in the presence of BTD-4APOc (10 and 100 M) to compare the effect of the probe in 
the cellular ROS disbalance. Results are visualized in Figure 12 and Figure S18. To avoid 
any possible fast reaction and allowing a more precise ROS quantification, all EPR 
experiments were carried out at liquid nitrogen temperature.  
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Figure 12. Effects of menadione, N-acetylcysteine (NAC) or BTD-4ApOc treatments on CM• formation 
in tumor cells. A higher CM• formation was observed in MCF-7 cells (p < 0.01) for menadione treatment 
only. **p < 0.01 compared to control group; one-way ANOVA, followed by Tukey's multiple comparison 
test.  
 
 As depicted in Figure 12, only the known ROS inductor menadione caused a 
significant ROS alteration in MCF-7 cells. At 10 M, BTD-4APOc did not induced any 
significant ROS alteration and could be compared with the basal cellular level (negative 
control). At 100 M, a small ROS alteration was noted but by far smaller than that 
observed for menadione induction, that is, the only statistically significant alteration 
induced by menadione. N-Acetylcysteine (NAC) caused a small ROS reduction, as 
expected for this compound.129 These results showed the new probe has no effect over 
the cellular normal function and homeostasis, thus rendering this probe as an outstanding 
mitochondrial marker.  
 
Conclusions 
In summary, a series of new fluorescent BTDs derivatives could be synthesized and 
applied as live cell-imaging probes. Their molecular architecture was designed to stain 
mitochondrial selectively, but the results described herein evidenced we are still at the 
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crawling stage in the science of predicting the relation between the molecular architecture 
fluorescent BTDs and their cellular responses. BTD-4AP showed a diffuse cytosol 
staining and could not be used to stain mitochondria at all, although the available evidence 
pointed firmly to this response. The classical strategy to induce mitochondrial selection, 
that is, the incorporation of TPP group in the fluorophore structure failed and the designed 
probe (BTD-4APBuP) proved to have a high and unexpected affinity for the plasma 
membrane. The other designed probe for mitochondrial selective staining (BTD-4APBu) 
showed a reasonable staining, but a clear leakage was noted and this feature does not 
allow its use as selective mitochondrial bioprobe. The molecular architecture of BTD-
4APBu associated with the cellular result allowed the development of a highly selective 
mitochondrial marker named BTD-4APOc, which not only stained mitochondrial in live 
and fixed cells, but it was also innocent on the ROS production at the organelle, as 
demonstrated by EPR experiments. BTD-4APOc did not alter the cellular basal ROS 
level neither interfered at the cellular homeostasis. Although we and other groups (see 
cited references) have already described huge advances on the use of fluorescent BTDs 
as selective cellular bioprobes, there are still much room for improvements, especially in 
the design and prediction of new molecular architecture aiming at selective staining inside 
the astonishing cellular world.  
 
Experimental section 
See the Experimental Section details in the Supporting Information File 
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